Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 14;13:1027449. doi: 10.3389/fimmu.2022.1027449

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Bai, Zhang, Liu and Quan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Immune-related activity, TMB, and TIDE analysis. The difference in immune-related activities (A) and tumor-infiltrating immune cells (B). The difference in somatic mutation characteristics (C, D) between the high- and low-risk groups. (E) TMB between the low-risk and high-risk groups of BLCA patients. (F, G) Survival curve in the different groups of BLCA patients. (H) TIDE scores between the low-risk and high-risk groups of BLCA patients. (F) shows that among bladder cancer patients, the high tumor mutation burden group (H-TMB) was associated with a better prognosis. **p < 0.01.